CA Stock MarketDetailed Quotes

NGEN NervGen Pharma Corp

Watchlist
  • 3.000
  • -0.130-4.15%
15min DelayMarket Closed Dec 20 16:00 ET
210.92MMarket Cap-7.89P/E (TTM)

NervGen Pharma Corp Key Stats

NervGen Pharma Corp Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CAD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2022/Q40.000 / 0.000--
--2022/Q30.000 / 0.000--
--2022/Q20.000 / 0.000--
--2021/Q40.000 / 0.000--
--2021/Q30.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2022/Q40.000 / 0.000--
--2022/Q30.000 / 0.000--
--2022/Q20.000 / 0.000--
--2021/Q40.000 / 0.000--
--2021/Q30.000 / 0.000--

Unlock Free Earnings Estimates

NervGen Pharma Corp Earnings Reports

Read more

Trending CA Stocks
Dividend Kings of Canada Dividend Kings of Canada

Dividend Kings In Canada are companies that have increased their Dividend per share for the most consecutive years, reflecting a strong business model and robust financials, and are likely to outperform the market with less volatility. Dividend Kings In Canada are companies that have increased their Dividend per share for the most consecutive years, reflecting a strong business model and robust financials, and are likely to outperform the market with less volatility.